Ngā hua rapu kaituhi :: APM

1

Homogeneous antibody-drug conjugates via site-selective disulfide bridging mā Nafsika Forte, Vijay Chudasama, James R. Baker

I whakaputaina 2018

Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
2

Antibody–PROTAC Conjugates Enable HER2-Dependent Targeted Protein Degradation of BRD4 mā Marı́a Maneiro, Nafsika Forte, Maria M. Shchepinova, Cyrille S. Kounde, Vijay Chudasama, James R. Baker, Edward W. Tate

I whakaputaina 2020

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
3

Tuning the Hydrolytic Stability of Next Generation Maleimide Cross-Linkers Enables Access to Albumin-Antibody Fragment Conjugates and tri-scFvs mā Nafsika Forte, Maria Livanos, Enrique Miranda, Maurício Morais, Xiaoping Yang, Vineeth Rajkumar, Kerry Chester, Vijay Chudasama, James R. Baker

I whakaputaina 2018

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
4

Targeted Protein Degradation through E2 Recruitment mā Nafsika Forte, Dustin Dovala, Matthew J. Hesse, Jeffrey M. McKenna, John A. Tallarico, Markus Schirle, Daniel K. Nomura

I whakaputaina 2023

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
5

Optimisation of the dibromomaleimide (DBM) platform for native antibody conjugation by accelerated post-conjugation hydrolysis mā Maurício Morais, João P. M. Nunes, Kersti Karu, Nafsika Forte, Irene Benni, Mark E. B. Smith, Stephen Caddick, Vijay Chudasama, James R. Baker

I whakaputaina 2017

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
6

Covalent Degrader of the Oncogenic Transcription Factor β-Catenin mā Flor A. Gowans, Nafsika Forte, J. D. Hatcher, Oscar W. Huang, Yangzhi Wang, Belen E. Altamirano Poblano, Ingrid E. Wertz, Daniel K. Nomura

I whakaputaina 2024

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i: